About
Operating Partner with over 35 years in the sector; former CEO of Atara Biotherapeutics and Global Head of Cell & Gene at Novartis Oncology. He represents Jeito on the boards of CatalYm and XyloCor Therapeutics.
Experience
- XyloCor Therapeutics, Inc.Member Board of Directorscurrent2025 — present
- RoslinCTMember Board of Directors- Global Strategy Advisorcurrent2025 — presentLondon Area, United Kingdom
- JEITOOperating Partnercurrent2025 — presentLondon Area, United Kingdom
- JEITOSpecial Advisor2022 — 2025San Francisco Bay Area
- CDR-Life Inc.Member Board of Directorscurrent2025 — present
- CatalYm GmbHMember Board of Directorscurrent2025 — present
- MedincellMember Board of Directorscurrent2025 — present
- IpsenMember Board of Directorscurrent2023 — presentParis Area, France
- Atara BiotherapeuticsChairman of the Board2024 — 2025California, United States
- Atara BiotherapeuticsPresident and CEO/ Member Board of Directors2019 — 2024San Francisco Bay Area
- Cogen Therapeutics, Inc.Member Board of Directors2018 — 2020Cambridge,USA
- NovartisSVP Global Head Cell & Gene2017 — 2019East Hanover, New Jersey, USA
- Navigate Biopharma Services Inc., A Novartis CompanyMember Board of Directors2017 — 2018Carlsbad, California, USA
- Novartis OncologySVP, Global Head Strategy, Business Development & Licensing2015 — 2017East Hanover, NJ (USA)
- Genoptix, A Novartis CompanyMember Board of Directors2016 — 2017Carlsbad, California, USA
- ServierSenior Executive Vice President SERVIER SAS and FIRS2015Greater Paris Metropolitan Region
- ServierHead of Business Development & Scientific Cooperation2009 — 2015Greater Paris Metropolitan Region
- ServierVice President Servier SAS, Business Development & Scientific Cooperation, Vice President FIRS2014 — 2015Greater Paris Metropolitan Region
- ServierHead Of Division2007 — 2009Greater Paris Metropolitan Region
- ServierHead of Northern Europe2003 — 2007Greater Paris Metropolitan Region
- ServierGeneral Manager France2000 — 2003Greater Paris Metropolitan Region
- Egis PharmaceuticalsMember of the Executive Comittee2015Greater Paris Metropolitan Region
- Servier InternationalHead Central & Eastern Europe1999 — 2000Greater Paris Metropolitan Region
- Servier PolskaGeneral Manager Poland1997 — 1999Warsaw Metropolitan Area
- Servier InternationalDeputy Regional Operations Manager UK, Australia, Russia1995 — 1997Greater Paris Metropolitan Region
- GlaxoWellcomeGroup Product Manager1994 — 1995Greater Paris Metropolitan Region
- GlaxoWellcomeInternational Product Manager1992 — 1993London Area, United Kingdom
- GlaxoWellcomeProduct Manager1991 — 1992Greater Paris Metropolitan Region
- VirbacHead of Marketing Asia1987 — 1990Taipei City, Taiwan
Skills & more
Strategy31Management5Biotechnology35Lifesciences10Oncology23Market Access22Pharmaceutical Sales10Sales Effectiveness16Cardiology4Neurology3Biopharmaceuticals7Healthcare4
+9 more
Business StrategyCompetitive AnalysisBusiness DevelopmentProduct LaunchM&A experienceLife SciencesCross-functional Team LeadershipCommercializationPharmaceutical IndustryFrom Pascal's professional profile.
Colleagues at Jeito Capital
Alain Rougon
Chief Financial Officer (external provider, Prodensia) at Jeito Capital
Anastasiya Sybirna
Principal at Jeito Capital
Annette Clancy
Pharma M&A Strategy at Jeito Capital
Benjamin Caillier
Finance Director, Jeito Capital at Jeito Capital
Boris Kere
Compliance Officer at Jeito Capital
Charlotte Formont
Senior Legal Counsel at Jeito Capital
Chloé Morlaàs
Investor Relations Director at Jeito Capital
Chloé Roche
Analyst at Jeito Capital
Frequently asked questions
- Who is Pascal Touchon?
- Operating Partner with over 35 years in the sector; former CEO of Atara Biotherapeutics and Global Head of Cell & Gene at Novartis Oncology. He represents Jeito on the boards of CatalYm and XyloCor Therapeutics.
- Where does Pascal Touchon work?
- Pascal Touchon is Operating Partner at Jeito Capital.
- Where did Pascal Touchon go to school?
- Pascal Touchon studied at INSEAD (MBA); IAE FRANCE - Écoles Universitaires de Management (DESS, Economics); Ecole Nationale Vétérinaire de Toulouse (Veterinary Medecine).
Same school
Also attended INSEAD1,084
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
.jpg)
+ 1,078 more
Also attended IAE FRANCE - Écoles Universitaires de Management12
Cyril EbersweilerGeneral Partner at SOSVSarah ShackeltonAdvisor at Delin VenturesAlexia PerouseManaging Partner and CEO at iBionextNicolas TruccoPartner at Pillar Multi Family OfficeWilliam JaccardPartner, CEO at Penta Monaco MFOIvan de LastoursInvestor at ATKA
+ 6 more
Also attended Ecole Nationale Vétérinaire de Toulouse2
Also attended Université Paul Sabatier Toulouse III13
Sarah ShackeltonAdvisor at Delin VenturesYago MontenegroVenture Partner at Mundi VenturesAlexandre BoulayInvestment Director at GO CapitalGabrielle BertierSenior Analyst at Finchley Healthcare VenturesSarah ShackeltonPartner, Talent at Jeito CapitalHagop AynedjianLimited Partner & Advisor at Formula VC
+ 7 more
Shared employers
Also worked at RoslinCT3
Also worked at JEITO25
Sarah ShackeltonAdvisor at Delin VenturesPierreInvestor at Sanofi VenturesKsenija PavleticGeneral Partner & Chief Commercial Officer at Jeito CapitalArnaud RousseauAsset Manager at Ginkgo Advisor SarlEloïse GirouxFinancial controller at Ginkgo Advisor SarlSabine DandiguianManaging Partner at Jeito Capital
+ 19 more
Also worked at Novartis173
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 167 more
